Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000591398 | SCV000705999 | uncertain significance | not provided | 2017-01-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001088167 | SCV001014909 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-11-21 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001805201 | SCV002050768 | likely benign | not specified | 2021-12-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002368015 | SCV002665119 | likely benign | Cardiovascular phenotype | 2021-07-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000591398 | SCV004150212 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |
Prevention |
RCV004530698 | SCV004708442 | likely benign | TTN-related disorder | 2021-07-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |